Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell‐clonotypic monoclonal antibody, 6B11
Carlos Julio Montoya(Rush University Medical Center), S. Brian Wilson(Massachusetts General Hospital), David Pollard(CTS Corporation (Czechia)), Kumud Kumari(Massachusetts General Hospital), Mark A. Atkinson(University of Florida), Candice Mulder(Rush University Medical Center), Clive Wasserfall(University of Florida), Marı́a Teresa Rugeles(Universidad de Antioquia), Jeffrey Martinson(Rush University Medical Center), Alan Landay(The University of Texas Medical Branch at Galveston)
Cited by 236
Related Papers
Type 1 diabetes
|The Lancet|2013|2.7k
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
|The Lancet|2001|1.5k
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
|Diabetes Care|2015|1.2k
The Pathogenesis of Insulin-Dependent Diabetes Mellitus
|New England Journal of Medicine|1994|1.1k